<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/60C296D8-B366-4F1D-8954-4EEC529861C4"><gtr:id>60C296D8-B366-4F1D-8954-4EEC529861C4</gtr:id><gtr:firstName>Pierluigi</gtr:firstName><gtr:surname>Nicotera</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U132664972"><gtr:id>16A895E5-F9F8-4279-A1A6-D7BF196506A7</gtr:id><gtr:title>Mechanisms of neuronal apoptosis and neurodegeneration</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U132664972</gtr:grantReference><gtr:abstractText>Like all our organs, the brain is exposed to potentially toxic agents. All cells that make up the brain react to injury by raising defences and stress responses that are similar to those they raise in the course of neurodegerative disorders such as stroke, Alzheimers, Parkinsons and other neurological diseases. Neurons are highly specialized brain cells that are essential for storing information and interact within a complex network with other neurons and brain cells to maintain essential vital functions. Hence any decrease in their function is likely to reduce quality of life. Major alterations of neuronal function include the inability to communicate and make contact with other brain cells. This can result in progressive pruning of the contact points (synapses) between neurons, which can then cause the disruption of the whole neuron. Loss of neurons and their synapses compromises vital functions including cognition, motor activity and the function of all major internal organs. ||Our research investigates the processes that are involved in the loss of neuronal connectivity and those that make neurons die when they are exposed to toxic agents or during neurodegenerative diseases. This will enable us to discover better and safer treatments for neurological diseases and better predict the risk of neurotoxicity posed by drugs or agents in the environment.</gtr:abstractText><gtr:technicalSummary>Chemical agents and endogenous noxious stimuli can cause neurotoxic effects by several mechanisms. Ultimately, impairment of neuronal signalling, synaptic activity and intracellular protein trafficking can result in neurodegeneration and neuronal demise. Establishing social contacts is the raison d etre of neurons throughout their entire life span. To form and retain functional connections, neuronal differentiation and death are ruthlessly regulated in development and kept strictly under control in post-mitotic systems. Derangements in neural networks affect neuronal populations at large. Therefore failure to retain synaptic connectivity is linked to dysfunction and often followed by neuronal death. Neuronal cell death is not an obligate requirement for neural dysfunction at the level of distributed circuits or local circuits. Nevertheless, more or less widespread neuronal loss can occur after acute insults such as brain ischemia or invasion of the brain by pathogens, but also at the end-stage of neurodegenerative and psychiatric diseases.||Our research is centred on the mechanisms leading to neurotoxicity in chemical injury and disease states. The identification of molecular switches that decide the type of cell death neurons undergo following injury has been one of our major interests in the past few years. ||We have characterized the metabolic requirements for cell death by apoptosis, and the role of different death sub-routines in the appearance of apoptosis or necrosis after excitotoxic injury.||In addition, we are studying the relative roles of loss of connectivity versus neuronal apoptosis in the onset of chronic neurodegenerative conditions.||Our major achievements include:||- The understanding of one of the major mechanisms that causes the excitotoxic Ca2+ overload in neurons during brain ischemia.||- The finding that statins can protect neurons from excess synaptic activity as found in excitotoxicity, but impair synaptic function and protein internalization in cortical neurons.||- The discovery that synaptic damage triggers two independent degenerative programmes in central neurons by a process that recapitulates the main features of CNS neurodegenerative disorders.||- The discovery that aggregate formation in a cellular model of Huntingtons disease impairs protein recycling through the vesicular recycling centre and thereby alters synaptic protein homeostasis.</gtr:technicalSummary><gtr:fund><gtr:end>2009-04-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-12-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>7158512</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>FD69781E-926E-4AFB-93FE-187FA0D9381A</gtr:id><gtr:title>Ageing, neuronal connectivity and brain disorders: an unsolved ripple effect.</gtr:title><gtr:parentPublicationTitle>Molecular neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d3e194b1caac581a3ee75169d19ffbb"><gtr:id>6d3e194b1caac581a3ee75169d19ffbb</gtr:id><gtr:otherNames>Bano D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0893-7648</gtr:issn><gtr:outcomeId>c8hNse7k2G3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>464E2224-0438-46E5-9121-274E3A1A37CB</gtr:id><gtr:title>The nystagmus-associated FRMD7 gene regulates neuronal outgrowth and development.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b6288dbdd76ee1cdeea3e0372ff95b4"><gtr:id>8b6288dbdd76ee1cdeea3e0372ff95b4</gtr:id><gtr:otherNames>Betts-Henderson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>b31CPUnHWJY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE6671D2-32B6-41DD-B4D4-857FCA4BDB5D</gtr:id><gtr:title>Targeting of the Arpc3 actin nucleation factor by miR-29a/b regulates dendritic spine morphology.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/776e9b5440e1bf312328d33c80a154a2"><gtr:id>776e9b5440e1bf312328d33c80a154a2</gtr:id><gtr:otherNames>Lippi G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>TpW2HsP1cCh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA04D405-3564-43BE-AD3E-CD84B98D04A6</gtr:id><gtr:title>Mitochondrial fragmentation and neuronal cell death in response to the Bcl-2/Bcl-x(L)/Bcl-w antagonist ABT-737.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb84028954a3fffabe84d3f8a4385ec2"><gtr:id>bb84028954a3fffabe84d3f8a4385ec2</gtr:id><gtr:otherNames>Young KW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>VYr5MYnqZzj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61C04EB0-070A-4A0E-9100-0CA4BE462E89</gtr:id><gtr:title>p73, miR106b, miR34a, and Itch in chronic lymphocytic leukemia.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/247414815407f8c50511cf613d791a43"><gtr:id>247414815407f8c50511cf613d791a43</gtr:id><gtr:otherNames>Rivetti di Val Cervo P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>c24Gcx296m8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D2005FE-4298-4C43-B902-6664B2F2BBE1</gtr:id><gtr:title>p73 regulates maintenance of neural stem cell.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dde82fd63c3f14b67506477d6f570a6a"><gtr:id>dde82fd63c3f14b67506477d6f570a6a</gtr:id><gtr:otherNames>Agostini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>KLN1pUMZewN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E3EBF02-C8B8-4D22-8EC6-C2ED0764C77A</gtr:id><gtr:title>Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1448bee0ae56bd58fecff6db43339f5"><gtr:id>a1448bee0ae56bd58fecff6db43339f5</gtr:id><gtr:otherNames>Bellodi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>q3GPLMFDhRt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F40E8447-441D-44FB-A24D-BC24439C0E61</gtr:id><gtr:title>Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be9c5a730374b716c07653875c443e50"><gtr:id>be9c5a730374b716c07653875c443e50</gtr:id><gtr:otherNames>Donnini S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>CS3ZrsTS5p4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F20215B-E3D8-4EA3-9CEC-A4DEBCCCE90D</gtr:id><gtr:title>Ryanodine receptor-2 upregulation and nicotine-mediated plasticity.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/988f5379d9b93f0a80f8e96af06ef35f"><gtr:id>988f5379d9b93f0a80f8e96af06ef35f</gtr:id><gtr:otherNames>Ziviani E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>esqhU7wKw39</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3756C96B-AC2F-4240-AAEC-D869662A5F4B</gtr:id><gtr:title>miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e6bd83dfd373c441dfe6211f736a6c"><gtr:id>36e6bd83dfd373c441dfe6211f736a6c</gtr:id><gtr:otherNames>Chen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>JyDMcNNxCEu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F85001B-AE58-4AF7-92E8-0DF1D2078FFF</gtr:id><gtr:title>p73: a multifunctional protein in neurobiology.</gtr:title><gtr:parentPublicationTitle>Molecular neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b96d284a976e2e36fed8ef55107a549"><gtr:id>6b96d284a976e2e36fed8ef55107a549</gtr:id><gtr:otherNames>Killick R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0893-7648</gtr:issn><gtr:outcomeId>qxE5E1F6Gn7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02FC56FF-E95B-4883-9626-28DE667D5E64</gtr:id><gtr:title>Different pathways lead to mitochondrial fragmentation during apoptotic and excitotoxic cell death in primary neurons.</gtr:title><gtr:parentPublicationTitle>Journal of biochemical and molecular toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb84028954a3fffabe84d3f8a4385ec2"><gtr:id>bb84028954a3fffabe84d3f8a4385ec2</gtr:id><gtr:otherNames>Young KW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1095-6670</gtr:issn><gtr:outcomeId>TSDdwz7XdEx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7920A15B-1330-4583-83FD-54B466E09F19</gtr:id><gtr:title>Loss of thymidine kinase 2 alters neuronal bioenergetics and leads to neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54515a3c8ed1b31a9355cf483d04656a"><gtr:id>54515a3c8ed1b31a9355cf483d04656a</gtr:id><gtr:otherNames>Bartesaghi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>eagVDpLkDZi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1927643D-112E-4CCB-85E6-A26D2BD36975</gtr:id><gtr:title>Pierluigi Nicotera. Interviewed by Karen Kaplan.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b45ae5185afec6d7a93b2151d1a43c8"><gtr:id>7b45ae5185afec6d7a93b2151d1a43c8</gtr:id><gtr:otherNames>Nicotera P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>Hthfj53AHyS</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U132664972</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>